← Evidence map

ArticleKidney international reports2024

Response to Letter to the Editor From Ville S. et al. About: "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy.

Federica Maritati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Response to Letter to the Editor From Ville S. et al. About: "Eculizumab First" in the Management of Posttransplant Thrombotic Microangiopathy. | OpenQuestion